Nyxoah S.A.
NASDAQ:NYXH
5.99 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.521 | 4.348 | 3.084 | 0.852 | 0.069 | 0 | 0 | 0 |
| Cost of Revenue
| 1.552 | 1.656 | 1.15 | 0.303 | 0.03 | 0.433 | 2.523 | 2.11 |
| Gross Profit
| 2.969 | 2.692 | 1.934 | 0.549 | 0.039 | -0.433 | -2.523 | -2.11 |
| Gross Profit Ratio
| 0.657 | 0.619 | 0.627 | 0.644 | 0.565 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 34.325 | 27.656 | 15.861 | 5.952 | 2.91 | 2.025 | 1.723 | 2 |
| General & Administrative Expenses
| 27.177 | 20.645 | 17.941 | 11.113 | 11.345 | 5.373 | 4.349 | 4.12 |
| Selling & Marketing Expenses
| 1.284 | 0 | 0.914 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 28.461 | 20.645 | 18.855 | 11.113 | 11.345 | 5.373 | 4.349 | 4.12 |
| Other Expenses
| -1.008 | -0.507 | -0.283 | 9.726 | -2.992 | -0.882 | 2.813 | 4.582 |
| Operating Expenses
| 61.778 | 47.794 | 34.433 | 26.791 | 11.263 | 6.516 | 8.45 | 10.143 |
| Operating Income
| -58.809 | -45.102 | -32.499 | -26.242 | -11.224 | -6.516 | -8.45 | -10.143 |
| Operating Income Ratio
| -13.008 | -10.373 | -10.538 | -30.8 | -162.667 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.377 | 0.445 | 2.443 | 1.603 | -0.928 | -0.669 | -0.588 | -0.191 |
| Income Before Tax
| -56.432 | -44.657 | -30.056 | -24.639 | -12.152 | -7.185 | -9.038 | -10.334 |
| Income Before Tax Ratio
| -12.482 | -10.271 | -9.746 | -28.919 | -176.116 | 0 | 0 | 0 |
| Income Tax Expense
| 2.804 | -1.445 | 1.169 | 2.98 | 0.093 | 0.07 | 0.041 | 0.037 |
| Net Income
| -59.236 | -43.212 | -31.225 | -27.619 | -12.245 | -7.255 | -9.079 | -10.371 |
| Net Income Ratio
| -13.102 | -9.938 | -10.125 | -32.417 | -177.464 | 0 | 0 | 0 |
| EPS
| -1.81 | -1.55 | -1.21 | -1.16 | -0.68 | -0.34 | -0.43 | -0.5 |
| EPS Diluted
| -1.81 | -1.55 | -1.21 | -1.16 | -0.68 | -0.34 | -0.43 | -0.5 |
| EBITDA
| -58.045 | -42.08 | -27.887 | -24.58 | -10.604 | -6.65 | -8.835 | -10.119 |
| EBITDA Ratio
| -12.839 | -9.678 | -9.042 | -28.85 | -153.681 | 0 | 0 | 0 |